HRA Pharma And Maxwellia To Launch The UK’s First OTC Daily Contraceptives
Executive Summary
The UK's MHRA has approved the Rx-to-OTC switch of two identical progestogen-only contraceptive pills from HRA Pharma and Maxwellia. Hana and Lovima (both 75mcg desogestrel) will be launched at the end of the month.
You may also be interested in...
Poland's Government Pushing To Restore OTC Access To Morning After Pill
As Poland is ranked the worst country in Europe for contraception access by a group of EU parliamentarians, the country's government has voted through a bill which would make the morning after pill available without a prescription for the first time in more than six years.
Maxwellia Adds STI Home-Test To UK Lovi Line
UK sexual health specialist Maxwellia continues to expand its UK footprint with an STI home-test launch under the Lovi brand umbrella.
Perrigo’s Rx-To-OTC Contraceptive Pill Switch Unanimously Rejected By German Committee
All nine present voting members of Germany's Expert Committee for Prescription rejected Perrigo's application to switch its progestogen-only contraceptive pill (desogestrel 75μg) from Rx to OTC status.